422 related articles for article (PubMed ID: 29371588)
41. Metabolomics-transcriptomics joint analysis: unveiling the dysregulated cell death network and developing a diagnostic model for high-grade neuroblastoma.
Zhang W; Zhang M; Sun M; Hu M; Yu M; Sun J; Zhang X; Du B
Front Immunol; 2023; 14():1345734. PubMed ID: 38239355
[TBL] [Abstract][Full Text] [Related]
42. Integrating bulk-seq and single-cell-seq reveals disulfidptosis potential index associating with neuroblastoma prognosis and immune infiltration.
Zhu A; Li X; Wang J
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16647-16658. PubMed ID: 37721569
[TBL] [Abstract][Full Text] [Related]
43. Target therapy for high-risk neuroblastoma treatment: integration of regulatory and scientific tools is needed.
Ceci A; Conte R; Didio A; Landi A; Ruggieri L; Giannuzzi V; Bonifazi F
Front Med (Lausanne); 2023; 10():1113460. PubMed ID: 37521350
[TBL] [Abstract][Full Text] [Related]
44. Therapy resistance in neuroblastoma: Mechanisms and reversal strategies.
Zhou X; Wang X; Li N; Guo Y; Yang X; Lei Y
Front Pharmacol; 2023; 14():1114295. PubMed ID: 36874032
[TBL] [Abstract][Full Text] [Related]
45. Changes in image-defined risk factors with neoadjuvant chemotherapy in pediatric abdominal neuroblastoma.
Wang H; Chen X; Zhu J; Zhang K; Lu J; Zhang L; Ding H; He L
Abdom Radiol (NY); 2022 Oct; 47(10):3520-3530. PubMed ID: 35790567
[TBL] [Abstract][Full Text] [Related]
46. Silencing of long chain noncoding RNA paternally expressed gene (PEG10) inhibits the progression of neuroblastoma by regulating microRNA-449a (miR-449a)/ribosomal protein S2 (RPS2) axis.
Zhang J; Liu W; Ji P; Zhang Y
Bioengineered; 2022 Mar; 13(3):6309-6322. PubMed ID: 35212607
[TBL] [Abstract][Full Text] [Related]
47. Synthetic Heterocyclic Derivatives as Kinase Inhibitors Tested for the Treatment of Neuroblastoma.
Musumeci F; Cianciusi A; D'Agostino I; Grossi G; Carbone A; Schenone S
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885651
[TBL] [Abstract][Full Text] [Related]
48. Role of Energy Metabolism in the Progression of Neuroblastoma.
Sakowicz-Burkiewicz M; Pawełczyk T; Zyśk M
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768850
[TBL] [Abstract][Full Text] [Related]
49. Neuroblastoma Cells Depend on CSB for Faithful Execution of Cytokinesis and Survival.
Paccosi E; Costantino M; Balzerano A; Filippi S; Brancorsini S; Proietti-De-Santis L
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576232
[TBL] [Abstract][Full Text] [Related]
50. Connectivity Map Analysis Indicates PI3K/Akt/mTOR Inhibitors as Potential Anti-Hypoxia Drugs in Neuroblastoma.
Uva P; Bosco MC; Eva A; Conte M; Garaventa A; Amoroso L; Cangelosi D
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199959
[TBL] [Abstract][Full Text] [Related]
51. Environment-Sensitive Polymeric Micelles Encapsulating SN-38 Potently Suppress Growth of Neuroblastoma Cells Exhibiting Intrinsic and Acquired Drug Resistance.
Polunin Y; Alferiev IS; Brodeur GM; Voronov A; Chorny M
ACS Pharmacol Transl Sci; 2021 Feb; 4(1):240-247. PubMed ID: 33615176
[TBL] [Abstract][Full Text] [Related]
52. Cell death in head and neck cancer pathogenesis and treatment.
Raudenská M; Balvan J; Masařík M
Cell Death Dis; 2021 Feb; 12(2):192. PubMed ID: 33602906
[TBL] [Abstract][Full Text] [Related]
53. MYCN Function in Neuroblastoma Development.
Otte J; Dyberg C; Pepich A; Johnsen JI
Front Oncol; 2020; 10():624079. PubMed ID: 33585251
[TBL] [Abstract][Full Text] [Related]
54. Molecular targeting therapies for neuroblastoma: Progress and challenges.
Zafar A; Wang W; Liu G; Wang X; Xian W; McKeon F; Foster J; Zhou J; Zhang R
Med Res Rev; 2021 Mar; 41(2):961-1021. PubMed ID: 33155698
[TBL] [Abstract][Full Text] [Related]
55. Nomogram for predicting overall survival in children with neuroblastoma based on SEER database.
Liang SW; Chen G; Luo YG; Chen P; Gu JH; Xu QQ; Dang YW; Qin LT; Lu HP; Huang WT; Huang ZG; Gao L; Chen JB
Ann Surg Treat Res; 2020 Aug; 99(2):118-126. PubMed ID: 32802817
[TBL] [Abstract][Full Text] [Related]
56. Gangliosides and Neuroblastomas.
Schengrund CL
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32726962
[TBL] [Abstract][Full Text] [Related]
57. Necroptosis and
Zhou H; Chen Z; Limpanont Y; Hu Y; Ma Y; Huang P; Dekumyoy P; Zhou M; Cheng Y; Lv Z
Front Microbiol; 2019; 10():3126. PubMed ID: 32038563
[TBL] [Abstract][Full Text] [Related]
58. Low UBE4B expression increases sensitivity of chemoresistant neuroblastoma cells to EGFR and STAT5 inhibition.
Memarzadeh K; Savage DJ; Bean AJ
Cancer Biol Ther; 2019; 20(12):1416-1429. PubMed ID: 31475882
[TBL] [Abstract][Full Text] [Related]
59. IGF1R facilitates epithelial-mesenchymal transition and cancer stem cell properties in neuroblastoma via the STAT3/AKT axis.
Wang XH; Wu HY; Gao J; Wang XH; Gao TH; Zhang SF
Cancer Manag Res; 2019; 11():5459-5472. PubMed ID: 31354352
[TBL] [Abstract][Full Text] [Related]
60. RDM1 promotes neuroblastoma growth through the RAS-Raf-MEK-ERK pathway.
Xie G; Wu H; Cai W; Chen M; Huang W; Yan W; Chang Y
FEBS Open Bio; 2019 Mar; 9(3):490-497. PubMed ID: 30868057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
